Our study provided evidence that BHGJT could directly inhibit lung cancer cells by dysregulating cell cycle-associated genes, such as CDK4 and Cyclin D1, and apoptosis-associated genes, such as Bax, Bad, BCL-2 and caspase 3. The gene discussed is CASP3; the disease is lung cancer.